Jeff Bezos Throws In With Anti-Aging Technology Startup Alto Labs

Following a stint in the media limelight championing a renewed space race, Amazon honcho Jeff Bezos has set his sights on getting in on the ground floor with a biotech startup’s anti-aging technology. Alto Labs has been gestating a biological reprogramming technology meant to rejuvenate cells. Scientists have noted that there’s potential for life-saving applications, body revitalization, and even the extension of the human lifespan.

In addition to catching the eye of Bezos, who previously provided financing for a similar effort through Unity Technologies, Alto Labs has attracted many investors and garnered $270 million in fundraising. The company was developed earlier this year following a two-day scientific conference headed by tech mogul and investor Yuri Milner. Alto is now recruiting top minds in the science field by offering salaries to the tune of $1 million and promising carte blanche for research methodology. These employees will likely be deployed to planned institutes in the U.S., U.K., and Japan.

Become a Subscriber

Please purchase a subscription to continue reading this article.

Subscribe Now

The technology in question, known as reprogramming, functions through “adding proteins to a cell which essentially instruct it to revert to a stem-cell-like state,” as explained by MIT Tech Review. Shinya Yamanaka earned a joint Nobel Prize in 2012 for demonstrating this technique on mice. He will become a part of Alto Labs by chairing its scientific advisory board.